You are here

July 09, 2019
Advocacy, Awareness

The Immunoglobulin Shortage: A Plea to Hospital-Based Prescribers and Pharmacists

POSTED BY: rdelaney

By John G. Boyle, President & CEO As the national patient organization for people living with primary immunodeficiency diseases (PI), the Immune Deficiency Foundation (IDF) continues to hear troubling reports about challenges patients are facing in accessing immunoglobulin (Ig) products. We are hearing these stories in alarming frequency both

Read More
July 02, 2019
President's News

Immunoglobulin Availability: New Battlefronts, Continuing Advocacy

POSTED BY:

By: John G. Boyle, President & CEO Each day, members of the Immune Deficiency Foundation (IDF) team hear new stories from families affected by primary immunodeficiency diseases (PI) about their challenges in accessing immunoglobulin (Ig) products. Many are a variation on the theme that we’ve been hearing all year. Some, however, show that the

Read More
July 02, 2019

Urgent: Biologic Withdrawal Information for Gamunex

POSTED BY: AFreestone

Grifols Therapeutics LLC has initiated a voluntary withdrawal of Gamunex. Click here to read the notification from the Patient Notification System.     

Read More
June 28, 2019
Community, Events

Thank You for Joining Us at the IDF 2019 National Conference

POSTED BY: rdelaney

The IDF 2019 National Conference, held in National Harbor, MD, June 20-22, brought together more than 1,300 attendees from 42 states, Washington, DC, and Australia, Canada, England, Germany, Iceland, Israel, Norway, and Portugal. This was the first IDF National Conference for 590 attendees. More than 80 educational sessions filled each day

Read More
June 28, 2019
In the News, Sponsors

Octapharma Introduces cutaquig® & IgCares™, Sponsors IDF National Conference

POSTED BY: AFreestone

Octapharma Introduces cutaquig® & IgCares™, Sponsors IDF National Conference. Click here to read the entire press release.    

Read More